首页> 外文期刊>American Journal of Neuroradiology >Mass Screening for Retrocochlear Disorders: Low-Field-Strength (0.2-T) versus High-Field-Strength (1.5-T) MR Imaging
【24h】

Mass Screening for Retrocochlear Disorders: Low-Field-Strength (0.2-T) versus High-Field-Strength (1.5-T) MR Imaging

机译:后耳蜗疾病的大规模筛查:低场强度(0.2-T)与高场强度(1.5-T)MR成像

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND PURPOSE: In patients with clinical symptoms suggestive of a retrocochlear disorder, contrast-enhanced T1-weighted spin-echo (SE) high-field-strength MR imaging is considered the criterion standard in assessing vestibular schwannoma. However, only 10–20% of its findings are pathologic. Our purpose was to prospectively compare the performance of low-field-strength MR imaging in screening for retrocochlear disorders, with high-field-strength MR imaging as the criterion standard. METHODS: A total of 287 patients with suspected retrocochlear disease underwent axial 1.5-T MR imaging with a T1-weighted SE sequence before and after contrast enhancement and with a high-resolution T2-weighted construction interference in steady state sequence. At immediate follow-up, the same patients underwent axial 0.2-T T1-weighted SE imaging without additional contrast enhancement. Results were classified as negative, positive, or uncertain and were analyzed in light of the patients’ clinical symptoms. RESULTS: MR imaging at 1.5 T depicted 63 disorders (21.95%), including 53 schwannomas, three other tumors, and seven other disorders (ie, gadolinium-enhancing inner ear, facial nerve, or meninges). MR imaging at 0.2 T showed evidence of 58 disorders; five disorders were not detected, although all schwannomas and other tumors were seen, including those smaller than 2 mm, and only two (28.6%) of the other disorders were detected. When correlated with clinical data, results showed that the five undetected disorders occurred in patients with unusual clinical signs. CONCLUSION: MR imaging at 0.2 T provided high sensitivity in detecting vestibular schwannoma of the internal auditory canal or cerebellopontine angle; it can be used for mass screening for this disease. Positive and uncertain imaging findings should be followed up with high-field-strength MR imaging.
机译:背景与目的:在临床症状提示后耳蜗疾病的患者中,考虑增强造影剂T1加权自旋回波(SE)高场强度MR成像评估前庭神经鞘瘤的标准 标准。但是,只有10–20%的 是病理性的。我们的目的是前瞻性地比较 的低场强度MR成像与高场强度 方法:总共287例疑似耳蜗后蜗疾病的患者接受了轴向1.5-T MR成像,并进行了T1加权 对比度增强前后的SE序列,并在稳定的 状态序列中具有 高分辨率T2加权构造干扰。在立即随访时,这些患者接受了 轴向0.2-T T1加权SE成像,而没有额外的对比 增强。结果分为阴性,阳性, 或不确定,并根据患者的 临床症状进行分析。 结果:1​​.5 T MR成像描述了63种疾病(21.95%), ,包括53例神经鞘瘤,其他3种肿瘤以及其他7种 疾病(即g增强的内耳,面神经, < / sup>或脑膜)。在0.2 T时的MR成像显示58种疾病的证据;虽然发现了所有神经鞘瘤和 其他肿瘤,包括小于2 mm的肿瘤和 仅检测到其他两种疾病(28.6%)。当 与临床数据相关时,结果表明五种 未被发现的疾病发生在具有异常临床 体征的患者中。 结论:0.2 T MR成像在 检测内耳道前庭神经鞘瘤或小脑桥骨角方面提供了高灵敏度;可用于对该疾病的大规模筛查 。阳性和不确定的影像学发现应 ,然后进行高场强MR成像。

著录项

  • 来源
    《American Journal of Neuroradiology》 |2002年第6期|918-923|共6页
  • 作者单位

    Department of Radiology, Hopital Huriez, Centre Hospitalier Universitaire de Lille, France;

    Department of Radiology, Hopital Huriez, Centre Hospitalier Universitaire de Lille, France;

    Department of Neurology, Hopital Huriez, Centre Hospitalier Universitaire de Lille, France;

    Department of Radiology, Hopital Huriez, Centre Hospitalier Universitaire de Lille, France;

    Department of Neurology, Hopital Huriez, Centre Hospitalier Universitaire de Lille, France;

    Department of Neurology, Hopital Huriez, Centre Hospitalier Universitaire de Lille, France;

    Department of Radiology, Hopital Huriez, Centre Hospitalier Universitaire de Lille, France;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号